HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM
Report
- Report Number
- 2248721-2010-00159
- Event Type
- Death
- Date Received
- November 4, 2010
- Date of Event
- October 1, 2010
- Report Date
- October 7, 2010
- Manufacturer
- INTERNATIONAL TECHNIDYNE CORP.
- Product Code
- JPA
- PMA / PMN Number
- K050016
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
THIS MDR SUBMITTED ON 11/04/2010 REFERENCES ITC COMPLAINT (B)(4). PATIENT DEATH WAS NOT DUE TO THE INSTRUMENT IN THIS REPORT. CUSTOMER INDICATED POST EVENT QUALITY CONTROL RESULTS DEMONSTRATED PROPER PERFORMANCE. MANUFACTURER AWAITING PRODUCT RETURN FOR FURTHER COMPLAINT EVALUATION. THERE ARE 2 STAGES TO DIC. IN THE EARLY STAGE, THERE IS WIDESPREAD ACTIVATION OF CLOTTING FACTORS. AT THIS STAGE, ACT IS EXPECTED TO BE VERY SHORT. AS DIC PROGRESSES, CLOTTING FACTORS ARE CONSUMED AND ANTI-CLOTTING FACTORS BECOME ACTIVATED. AT THIS STAGE, ACT IS TYPICALLY MARKEDLY PROLONGED. THE ACTS OBSERVED IN THIS COMPLAINT ARE CONSISTENT WITH THE 2 PHASES OF DIC, AND THEREFORE, THE (B)(4) OF ITC'S MEDICAL ADVISORY BOARD STATES THE INSTRUMENT PERFORMED AS EXPECTED. ITC COMPLAINT CASE ADDITIONAL REFERENCE: CASE (B)(4), MDR #2248721-2010-00150; CASE (B)(4), MDR #2248721-2010-00158; CASE (B)(4), MDR #2248721-2010-00159, CASE (B)(4), MDR #2248721-2010-00160. CUVETTE LOT #'S: G0JAC204, G0JAC118, E0JAC143. ITC HAS REQUESTED ALL DATA REQUIRED FOR FORM 3500A.
DEVICE 3 OF 4. CUSTOMER REPORTED VARIED RESULTS: OUTSIDE-REPORTABLE-RANGE-LOW, LOW ACT AND HIGH ACT RESULTS WITH THE SIGNATURE ELITE INSTRUMENT. TESTING TIME POINTS NOT SPECIFIED AND SPECIFIC INSTRUMENTS AND CUVETTE LOT NUMBERS NOT IDENTIFIED. NOTE: ONE MDR REPORTED FOR EACH SYSTEM SERIAL NUMBER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | HEMOCHRON SIGNATURE MICROCOAGULATION SYSTEM | SIGNATURE INST | JPA | INTERNATIONAL TECHNIDYNE CORP. | ELITE |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 67 YR | Death |